Goldman Sachs Maintains Neutral on Cerence, Raises Price Target to $9

Benzinga · 2d ago
Goldman Sachs analyst Mark Delaney maintains Cerence (NASDAQ:CRNC) with a Neutral and raises the price target from $8 to $9.